Pamela Wapnick

Companies

• Metagenomi Therapeutics, Inc.Chief financial officer Feb 8, 2024 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• MTMetagenomi Therapeutics, Inc. MGX206,580 shares²$168.3K at $0.81Sep 8, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Sep 8, 2026Sold 1,911 shares at $1.16 of Metagenomi Therapeutics, Inc.²
• Jun 5, 2026Sold 2,884 shares at $1.30 of Metagenomi Therapeutics, Inc.³
• Apr 1, 2026Granted 24,000 shares of Metagenomi Therapeutics, Inc.⁴
• Mar 5, 2026Sold 1,581 shares at $1.60 of Metagenomi Therapeutics, Inc.⁵
• Dec 5, 2025Sold 1,576 shares at $1.77 of Metagenomi Therapeutics, Inc.⁶
• Dec 1, 2025Granted 120,000 shares at $1.60 of Metagenomi Therapeutics, Inc.⁷
• Sep 5, 2025Sold 1,576 shares at $1.81 of Metagenomi Therapeutics, Inc.⁷
• Jun 6, 2025Sold 1,576 shares at $1.75 of Metagenomi Therapeutics, Inc.⁸
• Apr 1, 2025Granted 14,000 shares of Metagenomi Therapeutics, Inc.⁹
• Mar 5, 2025Sold 1,808 shares at $1.87 of Metagenomi Therapeutics, Inc.¹⁰
• Dec 5, 2024Sold 1,559 shares at $1.86 of Metagenomi Therapeutics, Inc.¹¹
• Sep 5, 2024Sold 6,265 shares at $2.88 of Metagenomi Therapeutics, Inc.¹²
• Apr 1, 2024Granted 69,316 shares of Metagenomi Therapeutics, Inc.¹³